4//SEC Filing
McKenzie Paul 4
Accession 0001127602-19-006088
CIK 0000875045other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 6:17 PM ET
Size
18.4 KB
Accession
0001127602-19-006088
Insider Transaction Report
Form 4
BIOGEN INC.BIIB
McKenzie Paul
EVP Pharmaceutical Oper & Tech
Transactions
- Exercise/Conversion
Common Stock
2019-02-12+1,263→ 5,639.631 total - Tax Payment
Common Stock
2019-02-12$319.43/sh−380$121,383→ 5,259.631 total - Exercise/Conversion
Common Stock
2019-02-12+1,799→ 7,058.631 total - Tax Payment
Common Stock
2019-02-12$319.43/sh−539$172,173→ 6,519.631 total - Exercise/Conversion
Restricted Stock Unit
2019-02-12−1,263→ 2,527 totalExercise: $0.00Exp: 2020-02-12→ Common Stock (1,263 underlying) - Exercise/Conversion
Restricted Stock Unit
2019-02-12−1,799→ 7,671 totalExercise: $0.00Exp: 2021-02-12→ Common Stock (1,799 underlying) - Other
Restricted Stock Unit
2019-02-12−1,357→ 6,314 totalExercise: $0.00Exp: 2021-02-12→ Common Stock (1,357 underlying) - Award
Restricted Stock Unit
2019-02-12+10,960→ 10,960 totalExercise: $0.00Exp: 2022-02-12→ Common Stock (10,960 underlying)
Footnotes (4)
- [F1]Includes 74.812 shares acquired under the Biogen Inc. employee stock purchase plan on 3/29/2018.
- [F2]The restricted stock units will vest in 2 annual installments. One-third will vest on the first anniversary of the grant date and two-thirds will vest on the second anniversary of the grant date.
- [F3]The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date]).
- [F4]This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested.
Documents
Issuer
BIOGEN INC.
CIK 0000875045
Entity typeother
Related Parties
1- filerCIK 0001677903
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 6:17 PM ET
- Size
- 18.4 KB